Stay updated with breaking news from Dmitriy Chekmarev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study suggests that Optibrium’s augmented chemistry can replace the need for human clinical trials when developing new flavor and fragrance ingredients.
Optibrium Limited, a leading provider of software and artificial intelligence (AI) solutions for drug discovery, has announced the publication of a peer-reviewed study in the Journal of Computer-Aided Molecular Design, “Imputation of Sensory Properties Using Deep Learning”.
The study demonstrates accuracy and predictive capability of proprietary deep learning method for developing flavours and fragrances, and in drug discovery.